Odontogenic CystsNCT05358275
The Evaluation of the Effect of Performing Guided Lid Surgery
A study testing surgical cutting guide with piezo in people with Odontogenic Cysts, run by Ain Shams University at 1 site in Egypt.
Trial summary
to evaluate the percentage of bone volume regain along with postoperative pain in cases done using the bone lid technique in comparison with those done using the conventional cyst enucleation technique. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Odontogenic Cysts
- What is being tested?
- surgical cutting guide with piezo
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Oct 2021to 1 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Age ranging from 18-60 years.
- Have free medical history or controlled systemic disease.
- Expansile cystic lesion with intact cortical bone extending from 2-6 teeth.
- A minimum thickness of 1 mm of the cortical bone.
Who cannot join
- Patients with history of surgery in the area affected by the cystic lesion.
- Patients with suspected malignant tumors in the area.
Trial locations and contacts
1 site in 1 country.
Marwa El Kassaby contact
Egypt1 site, 1 recruiting
- Recruiting
Ain shams University
Cairo, 11757
Marwa El Kassaby, 01006596242
About this study
Official title: The Evaluation of the Effect of Performing Guided Lid Surgery With Enucleation of Cystic Lesions Compared to Conventional Cystic Enucleation; a Randomized Clinical Trial
to evaluate the percentage of bone volume regain along with postoperative pain in cases done using the bone lid technique in comparison with those done using the conventional cyst enucleation technique.
Read the detailed description
The study will involve eighteen patients selected from the outpatient clinic, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Ain Shams University.
The patients included in this study will be informed about the full details of this research and they will sign an informed consent. Moreover, this research will be reviewed by the research ethics committee, Faculty of Dentistry, Ain Shams University.
Randomization:
The study consists of two groups each containing 10 patients. Patients will be randomly allocated according to predetermined computer-generated randomization using (www.randomizer.org).
PICO:
P: Patients with expansile cystic lesions with intact bony cortex of a minimum 1mm thickness.
I: Cyst enucleation using the bone lid technique and piezoelectric device. C: Cyst enucleation using the conventional buccal bone ostectomy technique. O: Percentage of bone volume recovery. T: 6 months postoperative.
Inclusion criteria:
- Age ranging from 18-60 years.
- Have free medical history or controlled systemic disease.
- Expansile cystic lesion with intact cortical bone extending from 2-6 teeth.
- A minimum thickness of 1 mm of the cortical bone.
Exclusion criteria:
- Patients with history of surgery in the area affected by the cystic lesion.
- Patients with suspected malignant tumors in the area.
Pre-operative assessment:
Proper history is obtained followed by palpation of the affected area to check tenderness or suspected superimposed infection. Aspiration biopsy is done to ensure the nature of the lesion being cystic. Cone Beam Computed Tomography (CBCT) is done to assess the exact size of the lesion and plan for the surgical cutting guide.
Patients with intact cortical bone related to the cystic lesion will be enrolled in this study. All patients will receive full information about the procedures where the risks and benefits will be thoroughly explained to them. They will then be asked to give their consent.
Sample size calculation:
Considering that there was around 93% difference between the cystic cavity before and after lid surgery with enucleation (19). After setting the α at 0.05 and β at 0.2; the minimal sample size was calculated and revealed that the minimum number to achieve statistical data was 10 patients in each goup (total number of patients= 20).
Pre-operative patient preparation:
- Fasting for 6-8 hours before the procedure.
- Laboratory investigations to assess his/ her medical condition if the procedure is to be performed under general anesthesia;
- Complete blood count (CBC).
- Bleeding profile; PT, PTT, INR.
- Liver function test.
- Kidney function test.
- Blood sugar level; fasting and 2-hours post-brandial.
Surgical procedure:
Anesthetizing the surgical area is done using the selected suitable nerve block technique with articaine 4% and 1:100,000 epinephrine.
- Flap reflection: A full thickness muco-periosteal flap is reflected using no.15 blade. The extent of the flap incisions shall involve one tooth mesial to the lesion and one tooth distal to the lesion.
- Surgical guide fixation: The surgical cutting guide is adapted in place and fixed using micro-screws to ensure proper stability of the guide and accuracy of the bony window.
- Bone lid fabrication: The bony window is cut guided by the edges in the cutting guide using piezoelectric device under copious irrigation. The window is then dissected bluntly from the attached cystic lesion using a muco-periosteal elevator and a bone curette.
- Enucleation of the cystic lesion: The lesion is carefully separated from the surrounding bone using a muco-periosteal elevator and a bone curette while being held with a toothed tissue forceps or Allis forceps. The excised lesion will be placed in a jar containing 10% formaldehyde to be sent to the Oral Pathology lab for excisional biopsy confirmation of the nature of the lesion. This is followed by careful curettage of the surgical bed to ensure absence of any remnants of the lesion followed by rinsing using isotonic saline solution.
- Fixation of the bone lid: The previously removed bone lid is reoriented back in place and fixed using 2.3 micro-plates and micro-screws for rigid fixation.
- Closure of the flap:
The flap is sutured using 4-0 vicryl resorbable suture to achieve primary closure.
The control group will be done using the conventional buccal ostectomy technique by reflection of a full thickness mucoperiosteal flap followed by removal of part of the cortical bone to allow enough access to the cystic lesion. The lesion is enucleated afterwards by removing the entire lining and the flap is closed at the end of the procedure using 4-0 vicryl resorbable suture. No surgical guide is used and the removed part of the cortical bone is grinded using a high speed handpiece, a rounded surgical bur and a bone curette.
Immediate post-operative medications:
- Amoxicillin/ clavulanate 1gm tablets every 12 hours for 5 days.
- Chymotrypsin 300E.A.U. 2 tablets every 8 hours for 5 days.
- Ibuprofen 600mg tablets every 12 hours for 5 days.
Immediate post-operative instructions:
- Avoid vigorous rinsing or spitting for the first 24 hours.
- Place ice packs over the surgical area for 10 minutes and repeated every 30 minutes over the first 6 hours.
- Avoid hot, hard or crunchy food for the first 3 days.
- After 24 hours, start rinsing with warm isotonic saline solution 3 times per day for 7 days.
- After 24 hours, start placing warm packs over the surgical area 3 times per day for 7 days.
Follow up:
- Percentage of bone volume regained will be evaluated using CBCT 6 months after the intervention (a total of 2 CBCTs; one pre-operative and one 6 months post-operative).
- Pain will be assessed immediately postoperative and after 6 months by Visual Analog Scale from (0-10), as 0 means absence of pain and 10 means maximum pain.
- Conditions
- Odontogenic Cysts
- Being tested
- surgical cutting guide with piezo, control
- Medical subject headings
- Odontogenic Cysts
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
surgical cutting guide with piezoDevice
3D planned lid surgery
controlOther
ordinary cyst enucleation
| Study group | Role | What they receive |
|---|---|---|
| study group | Experimental | Guided lid surgery is performed to reduce the loss of bone post operative Receives: Device: surgical cutting guide with piezo |
| control group | Active comparator | The patient will receive active ordinary treatment for removal of odontogenic cysts Receives: Other: control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Regain of bone volume
evaluation of formed bone using CBCT
Measured: 6 months
Secondary outcomes (1)
Pain with visual analogue scale
evaluation of pain by exposing patient to a visual analogue scale
Measured: one week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 May 2022
- Study start1 Oct 2021
- Primary completion1 Oct 2022 (estimated)
- Study completion1 Mar 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Odontogenic CystsStudies of the same condition, open and under way.
- More trials run by Ain Shams UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized clinical trial with 1:1 allocation ratio
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 18 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ain Shams University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yasser Mohamed Nabil Ahmed Khirat El Hadidi, Ain Shams University
- Investigators
- mohamed diaa, Study chair, Ain Shams University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05358275
- Sponsor's protocol ID
- 28-4-2022 OMFS
- Status last verified
- Apr 2022
- First submitted
- 28 Apr 2022
- Last updated
- 3 May 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Evaluation of the Effect of Performing Guided Lid Surgery With Enucleation of Cystic Lesions Compared to Conventional Cystic Enucleation; a Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT05358275
- Acronym / sponsor ID
- 28-4-2022 OMFS
- Conditions
- Odontogenic Cysts
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 18 participants (estimated)
- Lead sponsor
- Ain Shams UniversityUniversity, hospital or other
- Study start
- 1 Oct 2021 (actual)
- Primary completion
- 1 Oct 2022 (estimated)
- Study completion
- 1 Mar 2023 (estimated)
- First posted
- 3 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
to evaluate the percentage of bone volume regain along with postoperative pain in cases done using the bone lid technique in comparison with those done using the conventional cyst enucleation technique.
Detailed description
The study will involve eighteen patients selected from the outpatient clinic, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Ain Shams University.
The patients included in this study will be informed about the full details of this research and they will sign an informed consent. Moreover, this research will be reviewed by the research ethics committee, Faculty of Dentistry, Ain Shams University.
Randomization:
The study consists of two groups each containing 10 patients. Patients will be randomly allocated according to predetermined computer-generated randomization using (www.randomizer.org).
PICO:
P: Patients with expansile cystic lesions with intact bony cortex of a minimum 1mm thickness.
I: Cyst enucleation using the bone lid technique and piezoelectric device. C: Cyst enucleation using the conventional buccal bone ostectomy technique. O: Percentage of bone volume recovery. T: 6 months postoperative.
Inclusion criteria:
- Age ranging from 18-60 years.
- Have free medical history or controlled systemic disease.
- Expansile cystic lesion with intact cortical bone extending from 2-6 teeth.
- A minimum thickness of 1 mm of the cortical bone.
Exclusion criteria:
- Patients with history of surgery in the area affected by the cystic lesion.
- Patients with suspected malignant tumors in the area.
Pre-operative assessment:
Proper history is obtained followed by palpation of the affected area to check tenderness or suspected superimposed infection. Aspiration biopsy is done to ensure the nature of the lesion being cystic. Cone Beam Computed Tomography (CBCT) is done to assess the exact size of the lesion and plan for the surgical cutting guide.
Patients with intact cortical bone related to the cystic lesion will be enrolled in this study. All patients will receive full information about the procedures where the risks and benefits will be thoroughly explained to them. They will then be asked to give their consent.
Sample size calculation:
Considering that there was around 93% difference between the cystic cavity before and after lid surgery with enucleation (19). After setting the α at 0.05 and β at 0.2; the minimal sample size was calculated and revealed that the minimum number to achieve statistical data was 10 patients in each goup (total number of patients= 20).
Pre-operative patient preparation:
- Fasting for 6-8 hours before the procedure.
- Laboratory investigations to assess his/ her medical condition if the procedure is to be performed under general anesthesia;
- Complete blood count (CBC).
- Bleeding profile; PT, PTT, INR.
- Liver function test.
- Kidney function test.
- Blood sugar level; fasting and 2-hours post-brandial.
Surgical procedure:
Anesthetizing the surgical area is done using the selected suitable nerve block technique with articaine 4% and 1:100,000 epinephrine.
- Flap reflection: A full thickness muco-periosteal flap is reflected using no.15 blade. The extent of the flap incisions shall involve one tooth mesial to the lesion and one tooth distal to the lesion.
- Surgical guide fixation: The surgical cutting guide is adapted in place and fixed using micro-screws to ensure proper stability of the guide and accuracy of the bony window.
- Bone lid fabrication: The bony window is cut guided by the edges in the cutting guide using piezoelectric device under copious irrigation. The window is then dissected bluntly from the attached cystic lesion using a muco-periosteal elevator and a bone curette.
- Enucleation of the cystic lesion: The lesion is carefully separated from the surrounding bone using a muco-periosteal elevator and a bone curette while being held with a toothed tissue forceps or Allis forceps. The excised lesion will be placed in a jar containing 10% formaldehyde to be sent to the Oral Pathology lab for excisional biopsy confirmation of the nature of the lesion. This is followed by careful curettage of the surgical bed to ensure absence of any remnants of the lesion followed by rinsing using isotonic saline solution.
- Fixation of the bone lid: The previously removed bone lid is reoriented back in place and fixed using 2.3 micro-plates and micro-screws for rigid fixation.
- Closure of the flap:
The flap is sutured using 4-0 vicryl resorbable suture to achieve primary closure.
The control group will be done using the conventional buccal ostectomy technique by reflection of a full thickness mucoperiosteal flap followed by removal of part of the cortical bone to allow enough access to the cystic lesion. The lesion is enucleated afterwards by removing the entire lining and the flap is closed at the end of the procedure using 4-0 vicryl resorbable suture. No surgical guide is used and the removed part of the cortical bone is grinded using a high speed handpiece, a rounded surgical bur and a bone curette.
Immediate post-operative medications:
- Amoxicillin/ clavulanate 1gm tablets every 12 hours for 5 days.
- Chymotrypsin 300E.A.U. 2 tablets every 8 hours for 5 days.
- Ibuprofen 600mg tablets every 12 hours for 5 days.
Immediate post-operative instructions:
- Avoid vigorous rinsing or spitting for the first 24 hours.
- Place ice packs over the surgical area for 10 minutes and repeated every 30 minutes over the first 6 hours.
- Avoid hot, hard or crunchy food for the first 3 days.
- After 24 hours, start rinsing with warm isotonic saline solution 3 times per day for 7 days.
- After 24 hours, start placing warm packs over the surgical area 3 times per day for 7 days.
Follow up:
- Percentage of bone volume regained will be evaluated using CBCT 6 months after the intervention (a total of 2 CBCTs; one pre-operative and one 6 months post-operative).
- Pain will be assessed immediately postoperative and after 6 months by Visual Analog Scale from (0-10), as 0 means absence of pain and 10 means maximum pain.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized clinical trial with 1:1 allocation ratio
| Arm | Type | Receives |
|---|---|---|
| study group | Experimental | Device: surgical cutting guide with piezoGuided lid surgery is performed to reduce the loss of bone post operative |
| control group | Active comparator | Other: controlThe patient will receive active ordinary treatment for removal of odontogenic cysts |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Age ranging from 18-60 years.
- Have free medical history or controlled systemic disease.
- Expansile cystic lesion with intact cortical bone extending from 2-6 teeth.
- A minimum thickness of 1 mm of the cortical bone.
Key exclusion criteria (2 listed)
- Patients with history of surgery in the area affected by the cystic lesion.
- Patients with suspected malignant tumors in the area.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| surgical cutting guide with piezo3D planned lid surgery | Device | study group |
| controlordinary cyst enucleation | Other | control group |
Primary outcome
Regain of bone volume
Time frame: 6 months
evaluation of formed bone using CBCT
1 secondary outcome
Pain with visual analogue scale
Time frame: one week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2022.
- Individual participant dataSharing planned: No
Related trials for Odontogenic Cysts
Not yet recruiting
Osteogenic Potential of Topical Metformin Gel on Cystic Jaw Defects
Jaw Cysts, Metformin
Recruiting
Effect of Photobiomodulation on Pain and Healing of the Vertical Releasing Incision After Endodontic Microsurgery
Apical Periodontitis, Endodontically Treated Teeth
Active, not recruiting
Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.
Impact Molar, Mandible Cyst
RecruitingObservational study
Familial Investigations of Childhood Cancer Predisposition
Acute Leukemia, Adenomatous Polyposis
RecruitingObservational study
Patient Specific Implants (PSIs) for the Decompression of Odontogenic Cysts
Odontogenic Cysts, Odontogenic Keratocyst
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marwa El Kassaby contact
mohamed diaa study chair
Ain Shams University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing surgical cutting guide with piezo in people with Odontogenic Cysts, run by Ain Shams University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact yasser el hadidi (+201006596242, yasserelhadidi@asfd.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Regain of bone volume (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2022.